Company Name: ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company. The company is engaged in the development/commercialization of treatments for central nervous system disorders. The company’s FDA approved NUPLAZID™ is a treatment for Parkinson’s disease psychosis.
Ticker Symbol: ACAD (NASDAQ)
Company Website: www.acadia-pharm.com
Social Media: ACADIA Pharmaceuticals LinkedIn Page
Headquarters: San Diego, CA